Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights Evelo Biosciences, Inc.April 29, 2021 GMT –Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting– –Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors– –Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing markets– –Multiple clinical data readouts expected over next 18 months– –Management to host conference call at 8:30 a.m. ET–